Coeptis Therapeutics Holdings Cash Flow Statement 2019-2024 | COEP

Fifteen years of historical annual cash flow statements for Coeptis Therapeutics Holdings (COEP).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-21.27$-37.57$-13.45$-17.28$0.00
$1.00$1.00$0.45$0$0
$11.26$33.25$11.49$17.21$0
$12.27$34.25$11.94$17.21$0
$0.01$-0.01$0.02$0$0
$0$0$0$0$0
$1.32$-0.04$-1.58$0$0
$0.06$-0.49$-1.00$-0.05$0
$1.76$-0.55$-2.98$-0.05$0.00
$-7.24$-3.88$-4.49$-0.12$0.00
$0$0$0$0$0
$0$0$-1.75$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$-75.75$0
$0$0$0$-75.75$0
$0$0$0$0$0
$0.00$0.00$-1.75$-75.75$0
$-0.58$-2.42$-1.62$0$0
$0$0$0$-0.15$0.09
$-0.58$-2.42$-1.62$-0.15$0.09
$5.49$8.52$9.89$77.25$0
$5.49$8.52$9.89$77.25$0
$0$0$0$0$0
$0$-0.61$-0.05$-0.33$-0.09
$4.92$5.49$8.22$76.77$0.00
$-2.32$1.61$1.98$0.91$0.00
$11.83$32.12$10.15$0$0
$0$0$0$0$0